Phase II clinical trial of second-line FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer : AVASIRI trial
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-12-01
著者
-
YAMADA Yasuhide
Gastrointestinal Oncology Division, National Cancer Center Hospital
-
Kato Ken
Gastrointestinal Oncology Division National Cancer Center Hospital
-
Yamada Yasuhide
Gastrointestinal Oncology Division National Cancer Center Hospital
-
Shimada Yasuhiro
Gastrointestinal Medical Oncology Division, National Cancer Center Hospital
-
Hamaguchi Tetsuya
Gastrointestinal Medical Oncology Division, National Cancer Center Hospital
-
HIRASHIMA Yoshinori
Department of Medical Oncology, Faculty of Medicine, Oita University
-
HORITA Yosuke
Gastrointestinal Oncology Division, National Cancer Center Hospital
-
AKIYOSHI Kouhei
Gastrointestinal Oncology Division, National Cancer Center Hospital
-
NAGASHIMA Kengo
Laboratory of Biostatistics, Faculty of Pharmaceutical Sciences, Josai University
-
NAKAJIMA Takako
Gastrointestinal Oncology Division, National Cancer Center Hospital
関連論文
- Genetic Variations and Haplotypes of ABCC2 Encoding MRP2 in a Japanese Population
- Genetic variations and haplotype structures of the DPYD gene encoding dihydropyrimidine dehydrogenase in Japanese and their ethnic differences
- Adipocytokine levels in gastric cancer patients : resistin and visfatin as biomarkers of gastric cancer
- Genetic Variations and Frequencies of Major Haplotypes in SLCO1B1 Encoding the Transporter OATP1B1 in Japanese Subjects : SLCO1B1^*17 is More Prevalent Than ^*15
- Fourteen Novel Genetic Variations and Haplotype Structures of the TYMS Gene Encoding Human Thymidylate Synthase (TS)
- Genetic Variation and Haplotype Structure of the ABC Transporter Gene ABCG2 in a Japanese Population
- Phase I pharmacokinetic and pharmacogenomic study of E7070 administered once every 21 days
- Three novel single nucleotide polymorphisms in UGT1A10
- Impact of vascular endothelial growth factor receptor 1, 2, and 3 expression on the outcome of patients with gastric cancer
- Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples
- Prognostic significance of thymidylate synthase in patients with metastatic colorectal cancer who receive protracted venous infusions of 5-fluorouracil
- Phase I/II study of irinotecan, 5-fluorouracil, and l-leucovorin combination therapy (modified Saltz regimen) in patients with metastatic colorectal cancer
- Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts
- Phase I study of irinotecan and S-1 combination therapy in patients with metastatic gastric cancer
- CPT-11 Alters the Circadian Rhythm of Dihydropyrimidine Dehydrogenase mRNA in Mouse Liver
- Safety and pharmacokinetics of panitumumab in Japanese patients with advanced solid tumors
- Adipocytokines as new promising markers of colorectal tumors : Adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer
- Esophageal squamous cell carcinoma presenting with systemic arterial embolism
- Genetic Polymorphisms of Copper- and Platinum Drug-efflux Transporters ATP7A and ATP7B in Japanese Cancer Patients
- Phase I and pharmacokinetic study of vorinostat (suberoylanilide hydroxamic acid) in Japanese patients with solid tumors
- Genetic Polymorphisms of FCGRT Encoding FcRn in a Japanese Population and Their Functional Analysis
- Plasma concentrations of VCAM-1 and PAI-1 : A predictive biomarker for post-operative recurrence in colorectal cancer
- Systemic chemotherapy for peritoneal disseminated gastric cancer with inadequate oral intake : a retrospective study
- Identification of a candidate single-nucleotide polymorphism related to chemotherapeutic response through a combination of knowledge-based algorithm and hypothesis-free genomic data(BIOINFORMATICS)
- Phase II clinical trial of second-line FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer : AVASIRI trial